{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:48:29Z","timestamp":1760852909567,"version":"3.41.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1023\/a:1022597210629","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T18:03:18Z","timestamp":1048874598000},"page":"423-430","source":"Crossref","is-referenced-by-count":13,"title":["REVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far"],"prefix":"10.1007","volume":"48","author":[{"given":"Marilena","family":"Durazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Premoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Fagoonee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"462397_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(00)80425-0","volume":"32","author":"P Obermayer-Straub","year":"2000","unstructured":"Obermayer-Straub P, Stassburg CP, Manns MP: Autoimmune hepatitis. J Hepatol 32(1):181-197, 2000","journal-title":"J Hepatol"},{"key":"462397_CR2","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","volume":"45","author":"SZ Park","year":"2000","unstructured":"Park SZ, Nagorney DM, Czaja AJ: Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci 45:1944-1948, 2000","journal-title":"Dig Dis Sci"},{"key":"462397_CR3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PG Johnson","year":"1993","unstructured":"Johnson PG, McFarlane IG: Meeting report: international autoimmune hepatitis group. Hepatology 18:998-1005, 1993","journal-title":"Hepatology"},{"key":"462397_CR4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FP, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum B\u00fcschenfelde KH, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:928-937, 1999","journal-title":"J Hepatol"},{"issue":"3","key":"462397_CR5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","volume":"45","author":"M Lenzi","year":"1999","unstructured":"Lenzi M, Bellentani S, Saccoccio G, Muratori G, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C: Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45(3):435-441, 1999","journal-title":"Gut"},{"issue":"1","key":"462397_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in Norwegian population. Scand J Gastroenterol 33(1):99-103, 1998","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"462397_CR7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","volume":"16","author":"YM Lee","year":"2001","unstructured":"Lee YM, Teo EK, Ng TM, Khor C, Fock KM: Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 16(12):1384-1389, 2001","journal-title":"J Gastroenterol Hepatol"},{"key":"462397_CR8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/he.2000.5980","volume":"31","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH: Autoimmune hepatitis: the investigational and clinic challenges. Hepatology 31:1194-1200, 2000","journal-title":"Hepatology"},{"issue":"4","key":"462397_CR9","first-page":"279","volume":"43","author":"S Fagoonee","year":"2001","unstructured":"Fagoonee S, Pellicano R, Rizzetto M, Ponzetto A: The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med 43(4):279-282, 2001","journal-title":"Panminerva Med"},{"issue":"2","key":"462397_CR10","first-page":"85","volume":"43","author":"G Spinzi","year":"2001","unstructured":"Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia MA, Fagoonee S, Rizzetto M, Ponzetto A: Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med 43(2):85-87, 2001","journal-title":"Panminerva Med"},{"issue":"2","key":"462397_CR11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1013782408510","volume":"47","author":"M Durazzo","year":"2002","unstructured":"Durazzo M, Pellicano R, Premoli A, Berrutti M, Leone N, Ponzetto A, Rizzetto M: Helicobacter pylori seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci 47(2):380-283, 2002","journal-title":"Dig Dis Sci"},{"issue":"1","key":"462397_CR12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1023\/A:1005670111068","volume":"46","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Santrach PJ, Moore SB: Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 46(1):140-147, 2001","journal-title":"Dig Dis Sci"},{"issue":"1","key":"462397_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","volume":"35","author":"MA Heneghan","year":"2002","unstructured":"Heneghan MA, McFarlane IG: Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35(1):7-13, 2002","journal-title":"Hepatology"},{"key":"462397_CR14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","volume":"33","author":"HR Van Buuren","year":"2000","unstructured":"Van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP: High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33:543-548, 2000","journal-title":"J Hepatol"},{"key":"462397_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","volume":"49","author":"Z Ben-Ari","year":"2001","unstructured":"Ben-Ari Z, Czaja AJ: Autoimmune hepatitis and its variant syndromes. Gut 49:589-594, 2001","journal-title":"Gut"},{"issue":"38","key":"462397_CR16","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1055\/s-2008-1068269","volume":"112","author":"G Brunner","year":"1987","unstructured":"Brunner G, Klinge O: A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies(immunocholangitis). Dtsch Med Wochenschr 112(38):1454-1458, 1987","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"462397_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.1840180103","volume":"18","author":"Z Ben-Ari","year":"1993","unstructured":"Ben-Ari Z, Dhillon AP, Sherlock S: Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18(1):10-15, 1993.","journal-title":"Hepatology"},{"key":"462397_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","volume":"35","author":"P. Michieletti","year":"1994","unstructured":"Michieletti P. Wanless IR, Katz A, Schever PJ, Yeaman SJ, Bassendwe MF, Palmer JM, Haethcote EJ: Anti-mitochondrial antibodies negative primary biliary cirrhosis: a distinct sindrome of autoimmune cholangitis. Gut 35:260-265, 1994","journal-title":"Gut"},{"key":"462397_CR19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF02065530","volume":"40","author":"ZD Godman","year":"1995","unstructured":"Godman ZD McNally PR, Davis DR, Ishak KG: Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 40:1232-1242, 1995","journal-title":"Dig Dis Sci"},{"issue":"3","key":"462397_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00313029600169104","volume":"28","author":"K Omagari","year":"1996","unstructured":"Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney SJ, Whittingham S, Mackay IR: Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 28(3):255-258, 1996","journal-title":"Pathology"},{"key":"462397_CR21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","volume":"25","author":"P Invernizzi","year":"1997","unstructured":"Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, Zuin M, Podda M: Comparison of the clinical features and the clinical course of anti-mitochondrial antibodies positive and negative primary biliary cirrhosis. Hepatology 25:1090-1095, 1997","journal-title":"Hepatology"},{"issue":"2","key":"462397_CR22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1478-3231.1999.tb00021.x","volume":"19","author":"H Kinoshita","year":"1999","unstructured":"Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Khono S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR: Autoimmune cholangitis and primary biliary cirrhosis\u2014an autoimmune enigma. Liver 19(2):122-128, 1999","journal-title":"Liver"},{"issue":"7","key":"462397_CR23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","volume":"125","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ: The variant forms of autoimmune hepatitis. Ann Intern Med 125(7):588-598, 1996","journal-title":"Ann Intern Med"},{"issue":"2","key":"462397_CR24","first-page":"184","volume":"73","author":"S Sherlock","year":"1998","unstructured":"Sherlock S: Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin Proc 73(2):184-190, 1998","journal-title":"Autoimmune cholangitis: a unique entity? Mayo Clin Proc"},{"issue":"3","key":"462397_CR25","first-page":"191","volume":"23","author":"P Sanchez-Pobre","year":"1996","unstructured":"Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA: Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J Clin Gastroenterol 23(3):191-198, 1996","journal-title":"Atypical primary biliary cirrhosis or autoimmune cholangitis? J Clin Gastroenterol"},{"key":"462397_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","volume":"14","author":"R Perdigoto","year":"1992","unstructured":"Perdigoto R, Carpenter HA, Czaja AJ: Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 14:325-331, 1992","journal-title":"J Hepatol"},{"key":"462397_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-102-5-581","volume":"102","author":"A Wee","year":"1985","unstructured":"Wee A, Ludwig J: Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 102:581-587, 1985","journal-title":"Ann Intern Med"},{"key":"462397_CR28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","volume":"31","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31:1231-1238, 2000","journal-title":"Hepatology"},{"key":"462397_CR29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0753-3322(99)80095-X","volume":"53","author":"J Domoulin","year":"1999","unstructured":"Domoulin J, Leifeld L, Sauerbruch T, Spengler U: Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 53:242-254, 1999","journal-title":"Biomed Pharmacother"},{"key":"462397_CR30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","volume":"26","author":"WR Kim","year":"1997","unstructured":"Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD: Does anti-mitochondrial antibodies status affect response to treatment in patients with primary biliary cirrhosis? Outcames of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26:22-26, 1997","journal-title":"Hepatology"},{"key":"462397_CR31","first-page":"27","volume":"47","author":"M Durazzo","year":"2001","unstructured":"Durazzo M, Bresso F, Premoli A, Rabbione L: Variant syndromes in autoimmune hepatic diseases. Min Gastroenterol Dietol 47:27-38, 2001","journal-title":"Min Gastroenterol Dietol"},{"issue":"3","key":"462397_CR32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0168-8278(01)00176-3","volume":"35","author":"ME Gershwin","year":"2001","unstructured":"Gershwin ME: The natural history of primary biliary cirrhosis: of genes and cooperation. J Hepatol 35(3):412-415, 2001","journal-title":"J Hepatol"},{"issue":"2","key":"462397_CR33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28(2):296-301, 1998","journal-title":"Hepatology"},{"key":"462397_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0016-5085(76)80453-2","volume":"71","author":"AP Geubel","year":"1976","unstructured":"Geubel AP, Baggenstoss AH, Summerskill WH: Responses to treatment can differentiate crhonic active liver disease with cholangitis features from the primary biliary cirrhosis syndrome. Gastroenterology 71:444-449, 1976","journal-title":"Gastroenterology"},{"key":"462397_CR35","first-page":"542","volume":"72","author":"D Shouval","year":"1979","unstructured":"Shouval D, Levij IS, Eliakim M: Chronic active hepatitis with cholestatic features. Am J Gastroenterol 72:542-550, 1979","journal-title":"Am J Gastroenterol"},{"key":"462397_CR36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","volume":"31","author":"RP Kenny","year":"1986","unstructured":"Kenny RP, Czaja AJ, Ludwig J, Dickson ER: Frequency and significance in antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 31:705-711, 1986","journal-title":"Dig Dis Sci"},{"key":"462397_CR37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","volume":"28","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ: Frequency and nature of the variant sindromes of autoimmune liver disease. Hepatology 28:360-365, 1998","journal-title":"Hepatology"},{"key":"462397_CR38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","volume":"29","author":"WA Lohse","year":"1999","unstructured":"Lohse WA, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP: Characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: evidence for it being a hepatitic form of primary biliary cirrhosis in genetically susceptible individuals. Hepatology 29:1078-1084, 1999","journal-title":"Hepatology"},{"key":"462397_CR39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM: Primary biliary cirrhosis. N Engl J Med 335:1570-1580, 1996","journal-title":"N Engl J Med"},{"key":"462397_CR40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","volume":"334","author":"E Krawitt","year":"1996","unstructured":"Krawitt E: Autoimmune hepatits. N Engl J Med 334:897-903, 1996","journal-title":"N Engl J Med"},{"issue":"6","key":"462397_CR41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/VHHD-HTRU-N8J2-5X7R","volume":"116","author":"NS Goldstein","year":"2001","unstructured":"Goldstein NS, Soman A, Gordon SC: Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, midly active primary biliary cirrhosis and autoimmune hepatitis. Am J Clin Pathol 116(6):846-853, 2001","journal-title":"Am J Clin Pathol"},{"key":"462397_CR42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0676.1993.tb00648.x","volume":"13","author":"M Vyberg","year":"1993","unstructured":"Vyberg M: The hepatitis-associated bile duct lesion. Liver 13:289-301, 1993","journal-title":"Liver"},{"key":"462397_CR43","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(94)90829-X","volume":"107","author":"LA Colombato","year":"1994","unstructured":"Colombato LA, Alvarez F, Cote J, Huvet PM: Autoimmune cholangiopaty: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107:1839-1843, 1994","journal-title":"Gastroenterology"},{"issue":"2","key":"462397_CR44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","volume":"35","author":"S Joshi","year":"2002","unstructured":"Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ: Primary biliary cirrhosis additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 35(2):409-413, 2002","journal-title":"Hepatology"},{"key":"462397_CR45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0016-5085(92)90855-S","volume":"103","author":"Y Calmus","year":"1992","unstructured":"Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R: Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acid in the mause. Gastroenterology 103:617-621, 1992","journal-title":"Gastroenterology"},{"key":"462397_CR46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","volume":"40","author":"JC Duclos-Vallee","year":"1995","unstructured":"Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: corticoresistance and effective treatment with cyclosporine A. Dig Dis Sci 40:1069-1073, 1995","journal-title":"Dig Dis Sci"},{"issue":"2","key":"462397_CR47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.1840090208","volume":"9","author":"A Lobo-Yeo","year":"1989","unstructured":"Lobo-Yeo A, McSorley C, McFarlane BM, Mieli-Vergani G, Mowat AP, Vergani D: Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line. Hepatology 9(2):210-214, 1989","journal-title":"Hepatology"},{"key":"462397_CR48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G: Autoimmune hepatitis in childwood: a 20 year experience. Hepatology 25:541-547, 1997","journal-title":"Hepatology"},{"key":"462397_CR49","first-page":"1369","volume":"23","author":"KM Boberg","year":"1996","unstructured":"Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E: Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation on 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology 23:1369-1376, 1996","journal-title":"an evaluation on 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology"},{"key":"462397_CR50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","volume":"92","author":"M El-Shabrawi","year":"1987","unstructured":"El-Shabrawi M, Wilkinson ML, Portmann B, Mieli Vergani G, Chong SK, Williams R, Mowat AP: Primary sclerosing cholangitis in childwood. Gastroenterology 92:1226-1235, 1987","journal-title":"Gastroenterology"},{"key":"462397_CR51","first-page":"1415","volume":"22","author":"M Wilschanski","year":"1995","unstructured":"Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St. Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L, Roberts EA: Primary sclerosing cholangitis in 32 children: clinical laboratory and radiografic features with survival analysis. Hepatology 22:1415-1422, 1995","journal-title":"Hepatology"},{"key":"462397_CR52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","volume":"93","author":"AN McNair","year":"1998","unstructured":"McNair AN,Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in 5 cases. Am J Gastroenterol 93:777-784, 1998","journal-title":"Am J Gastroenterol"},{"key":"462397_CR53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya M, Angulo P, Lindor KD: Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 33:537-542, 2000","journal-title":"J Hepatol"},{"key":"462397_CR54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-1007301","volume":"14","author":"SP Lawrence","year":"1994","unstructured":"Lawrence SP, Sherman KE, Lawson JM, Goodman ZD: A 39 year-old man with chronic hepatitis. Semin Liv Dis 14:97-105, 1994","journal-title":"Semin Liv Dis"},{"key":"462397_CR55","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.1840220537","volume":"22","author":"D Wurbs","year":"1995","unstructured":"Wurbs D, Klein R, Terracciano LM, Berg PA, Bianchi L: A 28 year old woman with a combined hepatitc-cholestatic syndrome. Hepatology 22:1598-1605, 1995","journal-title":"Hepatology"},{"key":"462397_CR56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","volume":"24","author":"F Gohlke","year":"1996","unstructured":"Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH: Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 24:699-705, 1996","journal-title":"J Hepatol"},{"key":"462397_CR57","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1023\/A:1018845829198","volume":"42","author":"VA Luketic","year":"1997","unstructured":"Luketic VA, Gomez DA, Sanyal AJ, Shiffman ML: An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 42:2009-2016, 1997","journal-title":"Dig Dis Sci"},{"key":"462397_CR58","first-page":"207","volume":"46","author":"LB Seeff","year":"2000","unstructured":"Seeff LB: Strategies for assessing the long-term consequences of Hepatitis C virus infection. Min Gastroenterol Dietol 46:207-216, 2000","journal-title":"Min Gastroenterol Dietol"},{"key":"462397_CR59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","volume":"26","author":"F Cassani","year":"1997","unstructured":"Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB: Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26:561-566, 1997","journal-title":"Hepatology"},{"issue":"2","key":"462397_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0016-5085(95)90074-8","volume":"108","author":"M Durazzo","year":"1995","unstructured":"Durazzo M, Philipp T, Van Pelt FN, Lutting B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP: Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. Gastroenterology 108 (2):455-462, 1995","journal-title":"Gastroenterology"},{"key":"462397_CR61","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","volume":"16","author":"F Lunel","year":"1992","unstructured":"Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC: Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630-636, 1992","journal-title":"Hepatology"},{"key":"462397_CR62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/gut.45.3.328","volume":"45","author":"D Vergani","year":"1999","unstructured":"Vergani D: NOSA in HCV infection: markers or makers of disease? Gut 45:328-329, 1999","journal-title":"Gut"},{"key":"462397_CR63","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0168-8278(96)80228-5","volume":"25","author":"F Bortolotti","year":"1996","unstructured":"Bortolotti F, Vajro P, Balli F, Crivellario C, Barbera C, Cataleta M, Muratori L, Pontisso P, Nebbia G, Zancan L, Bertolini A, Alberti A, Bianchi F: Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 25:614-620, 1996","journal-title":"J Hepatol"},{"key":"462397_CR64","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510260438","volume":"26","author":"MP Manns","year":"1997","unstructured":"Manns MP, Obermayer-Straub P: Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 26:1054-1066, 1997","journal-title":"Hepatology"},{"key":"462397_CR65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.510260229","volume":"26","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Carpenter HA: Histological findings in chronic hepatitis C with autoimmune features. Hepatology 26:459-466, 1997","journal-title":"Hepatology"},{"key":"462397_CR66","first-page":"371","volume-title":"Viral Hepatitis: Diagnosis, Treatment, Prevention","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ: Overlap of chronic viral hepatitis and autoimmune hepatitis. In Viral Hepatitis: Diagnosis, Treatment, Prevention. RA Wilson (ed). New York, Marcel Dekker, 1997, pp 371-399"},{"key":"462397_CR67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-1827.2000.01015.x","volume":"50","author":"H Hano","year":"2000","unstructured":"Hano H, Takasaki S, Nakayama J: Autoimmune forms of chronic hepatitis associated with hepatitis C virus (HCV) infection with and without HCV-RNA: histological differences from pure autoimmune hepatitis and chronic hepatitis C. Pathol Int 50:106-112, 2000","journal-title":"Pathol Int"},{"key":"462397_CR68","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM1 antibodies recognize a short linear sequenze in P450IID6, a cytochrome P450 monooxygenase. J Clin Invest 88:1370-1378, 1991","journal-title":"J Clin Invest"},{"key":"462397_CR69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0140-6736(92)91332-3","volume":"339","author":"G Michel","year":"1992","unstructured":"Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde KH, Decker R, Manns MP: Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267-269, 1992","journal-title":"Lancet"},{"issue":"8","key":"462397_CR70","first-page":"1206","volume":"90","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90(8):1206-1211, 1995","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"462397_CR71","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840220506","volume":"22","author":"L Todros","year":"1995","unstructured":"Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, Verme G, Rizzetto M: Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver kidney microsomes. Hepatology 22(5):1374-1378, 1995","journal-title":"Hepatology"},{"key":"462397_CR72","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","volume":"112","author":"MD Strettel","year":"1997","unstructured":"Strettel MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R: Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112:2028-2035, 1997","journal-title":"Gastroenterology"},{"key":"462397_CR73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","volume":"57","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ: Drug therapy in the management of autoimmune hepatitis 1. Drugs 57:49-68, 1999","journal-title":"Drugs"},{"key":"462397_CR74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8278(05)80395-2","volume":"21","author":"L Muratori","year":"1994","unstructured":"Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB: Interferon therapy in liver\/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 21:199-203, 1994","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022597210629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1022597210629\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022597210629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T02:41:19Z","timestamp":1753756879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1022597210629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["462397"],"URL":"https:\/\/doi.org\/10.1023\/a:1022597210629","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}